Search results
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Rome Sentinel· 3 days agoAdalimumab-aaty is also available from Celltrion USA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty ...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 4 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 11 hours agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Avage Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
WebMD· 3 days agoRead the Patient Information Leaflet if available from your pharmacist before you start using tazarotene and each time you get a refill. This medication is for use on the skin only. Apply this ...
Fabior Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
WebMD· 3 days agoRead the Patient Information Leaflet if available from your pharmacist before you start using tazarotene and each time you get a refill. This medication is for use on the skin only. Wash and ...
Biogen (NASDAQ:BIIB) Given New $342.00 Price Target at HSBC
ETF DAILY NEWS· 6 days agoBiogen (NASDAQ:BIIB – Free Report) had its price objective boosted by HSBC from $339.00 to $342.00 in a research note published on Friday morning, Benzinga reports. BTIG Research restated a ...